Stocks and Investing Stocks and Investing
Fri, June 16, 2023
Thu, June 15, 2023
Wed, June 14, 2023
Tue, June 13, 2023

Alexander Nowak Maintained (TNDM) at Strong Buy with Decreased Target to $50 on, Jun 13th, 2023


Published on 2024-10-28 04:20:04 - WOPRAI, Alexander Nowak
  Print publication without navigation


Alexander Nowak of Craig-Hallum, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Strong Buy with Decreased Target from $74 to $50 on, Jun 13th, 2023.

Alexander has made no other calls on TNDM in the last 4 months.



There are 8 other peers that have a rating on TNDM. Out of the 8 peers that are also analyzing TNDM, 4 agree with Alexander's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $38 on, Thursday, May 4th, 2023
  • Larry Biegelsen of "Wells Fargo" Maintained at Hold with Decreased Target to $40 on, Thursday, May 4th, 2023
  • Jayson Bedford of "Raymond James" Downgraded from Buy to Hold on, Monday, April 24th, 2023
  • Danielle Antalffy of "UBS" Initiated at Hold and Held Target at $45 on, Wednesday, March 29th, 2023


These are the ratings of the 4 analyists that currently disagree with Alexander


  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $45 on, Monday, June 5th, 2023
  • Travis Steed of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $33 on, Friday, May 5th, 2023
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $52 on, Thursday, February 23rd, 2023
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $50 on, Thursday, February 23rd, 2023